Proxibarbal

CHEMBL2105233 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
226.2 g/mol
LogP
0.2
Phase
4

Proxibarbal is a barbiturate-class anticonvulsant and sedative-hypnotic that enhances GABA-A receptor-mediated inhibitory neurotransmission by prolonging chloride channel opening time and at higher concentrations directly activating the chloride channel. It was used for the management of epilepsy and as a sedative, though like all barbiturates it carries significant risk of dependence and respiratory depression.

الوزن الجزيئي

226,2300 g/mol

LogP

0,20

TPSA

95,50 Ų

قاعدة ليبينسكي للخمسة

ناجح

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O

InChI

InChI=1S/C10H14N2O4/c1-3-4-10(5-6(2)13)7(14)11-9(16)12-8(10)15/h3,6,13H,1,4-5H2,2H3,(H2,11,12,14,15,16)

Molecular Formula

C10H14N2O4

HBD / HBA

3 / 4

الروابط القابلة للدوران

4

الذرات الثقيلة

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Proxibarbal is a barbiturate-class anticonvulsant and sedative-hypnotic that enhances GABA-A receptor-mediated inhibitory neurotransmission by prolonging chloride channel opening time and at higher concentrations directly activating the chloride channel. It was used for the management of epilepsy and as a sedative, though like all barbiturates it carries significant risk of dependence and respiratory depression.

Yes, Proxibarbal is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105233. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 17336. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.